Patent · US Active

ALK polypeptides and methods of use thereof

US11623002B2 · kind B2 · utility

1Cited by

3References

5Claims

0Family size

Assignee

Elicio Therapeutics, Inc. · US

Inventors

Adrienne Li · Cambridge, US
Jackson Eby · Menlo Park, US
Peter C. DEMUTH · Cambridge, US

Key dates

Filing date	Jan 27, 2017
Grant date	Apr 11, 2023
Priority date	—
Expiry date	Oct 23, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention features immunogenic compositions containing anaplastic lymphoma kinase (ALK) polypeptides and methods of use thereof. The immunogenic compositions and methods of the invention may be used to treat a disease associated with ALK in a subject, such as cancer (e.g., a solid tumor cancer or an ALK+ cancer).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.